Symbol="GLMD"
AssetType="Common Stock"
Name="Galmed Pharmaceuticals Ltd"
Description="Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases. The company is headquartered in Tel Aviv, Israel."
CIK="1595353"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="16 ZE'EV TYOMKIN ST. (4TH FL.), TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1686100"
EBITDA="-11668000"
PERatio="None"
PEGRatio="0"
BookValue="6.28"
DividendPerShare="0"
DividendYield="0"
EPS="-8.2"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.397"
ReturnOnEquityTTM="-0.73"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-8.2"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.48"
EVToRevenue="-"
EVToEBITDA="0.51"
Beta="0.915"
num_52WeekHigh="14.18"
num_52WeekLow="0.77"
num_50DayMovingAverage="2.097"
num_200DayMovingAverage="1.226"
SharesOutstanding="2060200"
DividendDate="None"
ExDividendDate="None"
symbol="GLMD"
open="0.79"
high="0.90"
low="0.78"
price="0.88"
volume="30378.00"
latest_trading_day="2023-08-21"
previous_close="0.80"
change="0.07"
change_percent="9.2378%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="316247"
Change_recent_avg="-0.05"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-3.12"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_negative_thumbnail_id_2="493"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="624"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0084.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
